[1]
|
Siegel, R.L., Miller, K.D., Fuchs, H.E., et al. (2022) Cancer Statistics, 2022. CA: A Cancer Journal for Clinicians, 72, 7-33. https://doi.org/10.3322/caac.21708
|
[2]
|
曹瑾瑾, 李佳, 李奇灵, 等. 子宫内膜癌筛查策略[J]. 中国实用妇科与产科杂志, 2023, 39(11): 1062-1065.
|
[3]
|
Li, C., Yu, J. and Fu, Z. (2021) Application of CT and MRI Com-bined with VEGF-C and EGFR in the Identification of Endometrial Cancer Stages. American Journal of Translational Research, 13, 7164-7171.
|
[4]
|
李玲玲, 李赫, 李舰, 等. 结合分子分型的子宫内膜癌患者淋巴结转移的危险因素分析[J]. 中华妇产科杂志, 2023, 58(10): 733-741.
|
[5]
|
Lu, K.H. and Broaddus, R.R. (2020) Endometrial Cancer. New England Journal of Medicine, 383, 2053-2064.
https://doi.org/10.1056/NEJMra1514010
|
[6]
|
Benedet, J.L., Bender, H., Jones, H., et al. (2000) FIGO Staging Classifications and Clinical Practice Guidelines in the Management of Gynecologic Cancers. FIGO Committee on Gyne-cologic Oncology. International Journal of Gynecology & Obstetrics, 70, 209-262. https://doi.org/10.1016/S0020-7292(00)90001-8
|
[7]
|
李淑祎, 王青. 子宫内膜癌术前影像学检查及分期研究进展[J]. 中国中西医结合影像学杂志, 2021, 19(4): 402-404.
|
[8]
|
Knific, T., Osredkar, J., Smrkolj, P., et al. (2017) Novel Algorithm Including CA-125, HE4 and Body Mass Index in the Diagnosis of Endometrial Cancer. Gynecologic Oncology, 147, 126-132.
https://doi.org/10.1016/j.ygyno.2017.07.130
|
[9]
|
Crosbie, E.J., Kitson, S.J., McAlpine, J.N., et al. (2022) Endo-metrial Cancer. The Lancet, 399, 1412-1428.
https://doi.org/10.1016/S0140-6736(22)00323-3
|
[10]
|
Liu, F., Cheung, E.C.W. and Lao, T.T. (2021) Obesity In-creases Endometrial Cancer Risk in Chinese Women with Postmenopausal Bleeding. Menopause (New York, NY), 28, 1093-1098.
https://doi.org/10.1097/GME.0000000000001822
|
[11]
|
Goodman, A. (2021) Is Obesity Predictive of Endometrial Cancer for Women with Postmenopausal Bleeding? Menopause, 28, 1081-1082. https://doi.org/10.1097/GME.0000000000001861
|
[12]
|
Lundberg, F.E., Iliadou, A.N., Rodriguez-Wallberg, K., et al. (2019) The Risk of Breast and Gynecological Cancer in Women with a Diagnosis of Infertility: A Nationwide Popula-tion-Based Study. European Journal of Epidemiology, 34, 499-507. https://doi.org/10.1007/s10654-018-0474-9
|
[13]
|
Skalkidou, A., et al. (2017) Risk of Endometrial Cancer in Wom-en Treated with Ovary-Stimulating Drugs for Subfertility. Cochrane Database of Systematic Reviews, 3, CD010931. https://doi.org/10.1002/14651858.CD010931.pub2
|
[14]
|
Bagepalli, S.S., Kubakaddi, S.S., Polisetti, S., et al. (2020) A Novel Risk-Scoring Model for Prediction of Premalignant and Malignant Lesions of Uterine Endometrium among Symptomatic Premenopausal Women. International Journal of Women’s Health, 12, 883-891. https://doi.org/10.2147/IJWH.S268169
|
[15]
|
Giannella, L., Cerami, L.B., Setti, T., et al. (2019) Prediction of En-dometrial Hyperplasia and Cancer among Premenopausal Women with Abnormal Uterine Bleeding. BioMed Research International, 2019, Article ID: 8598152.
https://doi.org/10.2147/IJWH.S268169
|
[16]
|
Nicklin, J., Janda, M., Gebski, V., et al. (2012) The Utility of Serum CA-125 in Predicting Extra-Uterine Disease in Apparent Early-Stage Endometrial Cancer. International Journal of Can-cer, 131, 885-890.
https://doi.org/10.1002/ijc.26433
|
[17]
|
Nithin, K.U., Sridhar, M.G., Srilatha, K., et al. (2018) CA125 Is a Better Marker to Differentiate Endometrial Cancer and Abnormal Uterine Bleeding. African Health Sciences, 18, 972-978. https://doi.org/10.4314/ahs.v18i4.17
|
[18]
|
D’Ambrosio, V., Brunelli, R., Musacchio, L., et al. (2021) Adnexal Masses in Pregnancy: An Updated Review on Diagnosis and Treatment. Tumori Journal, 107, 12-16. https://doi.org/10.1177/0300891620909144
|
[19]
|
Li, J., Wang, X., Qu, W., et al. (2019) Comparison of Serum Human Epididymis Protein 4 and CA125 on Endometrial Cancer Detection: A Meta-Analysis. Clinica Chimica Acta, 488, 215-220. https://doi.org/10.1016/j.cca.2018.11.011
|
[20]
|
Brennan, D.J., Hackethal, A., Metcalf, A.M., et al. (2014) Serum HE4 as a Prognostic Marker in Endometrial Cancer—A Population Based Study. Gynecologic Oncology, 132, 159-165. https://doi.org/10.1016/j.ygyno.2013.10.036
|
[21]
|
Degez, M., Chauvire-Drouard, H., Leroy, A., Lair, M., Winer, D., et al. (2021) Endometrial Cancer: A Systematic Review of HE4, REM and REM-B. Clinica Chimica Acta: International Journal of Clinical Chemistry and Applied Molecular Biology, 515, 27-36. https://doi.org/10.1016/j.cca.2020.12.029
|
[22]
|
Prueksaritanond, N., Cheanpracha, P. and Yanaranop, M. (2016) Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Pa-tients at Rajavithi Hospital. Asian Pacific Journal of Cancer Prevention, 17, 1489-1492. https://doi.org/10.7314/APJCP.2016.17.3.1489
|
[23]
|
Quan, Q., Liao, Q., Yin, W., et al. (2021) Serum HE4 and CA125 Combined to Predict and Monitor Recurrence of Type II Endometrial Carcinoma. Scientific Reports, 11, Article No. 21694.
https://doi.org/10.1038/s41598-021-01263-w
|
[24]
|
Lin, D., Zhao, L., Zhu, Y., et al. (2021) Combination IETA Ul-trasonographic Characteristics Simple Scoring Method with Tumor Biomarkers Effectively Improves the Differentiation Ability of Benign and Malignant Lesions in Endometrium and Uterine Cavity. Frontiers in Oncology, 11, Article ID: 605847. https://doi.org/10.3389/fonc.2021.605847
|
[25]
|
Wynants, L., Verbakel, J.Y.J., Valentin, L., et al. (2022) The Risk of Endometrial Malignancy and Other Endometrial Pathology in Women with Abnormal Uterine Bleeding: An Ultrasound-Based Model Development Study by the IETA Group. Gynecologic and Obstetric Investigation, 87, 54-61. https://doi.org/10.1159/000522524
|
[26]
|
Hao, Y., Ren, G., Yang, W., et al. (2020) Combination Diagnosis with Elastography Strain Ratio and Molecular Markers Effectively Improves the Diagnosis Rate of Small Breast Cancer and Lymph Node Metastasis. Quantitative Imaging in Medicine and Surgery, 10, 678-691. https://doi.org/10.21037/qims.2020.02.14
|
[27]
|
Opolskiene, G., Sladkevicius, P. and Valentin, L. (2007) Ultrasound Assessment of Endometrial Morphology and Vascularity to Predict Endometrial Malignancy in Women with Postmeno-pausal Bleeding and Sonographic Endometrial Thickness > or = 4.5 mm. Ultrasound in Obstetrics & Gynecology, 30, 332-340. https://doi.org/10.1002/uog.4104
|
[28]
|
Sladkevicius, P., et al. (2017) Prospective Temporal Validation of Mathematical Models to Calculate Risk of Endometrial Malignancy in Patients with Postmenopausal Bleeding. Ultra-sound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 49, 649-656.
https://doi.org/10.1002/uog.15941
|
[29]
|
Opolskiene, G., Sladkevicius, P. and Valentin, L. (2011) Prediction of En-dometrial Malignancy in Women with Postmenopausal Bleeding and Sonographic Endometrial Thickness ≥ 4.5 mm. Ul-trasound in Obstetrics & Gynecology, 37, 232-240. https://doi.org/10.1002/uog.8871
|
[30]
|
Dueholm, M., Møller, C., Rydbjerg, S., et al. (2014) An Ultrasound Algorithm for Identification of Endometrial Cancer. Ultrasound in Obstet-rics & Gynecology, 43, 557-568. https://doi.org/10.1002/uog.13205
|
[31]
|
Dueholm, M., Hjorth, I.M.D., Dahl, K., et al. (2019) Ultrasound Scoring of Endometrial Pattern for Fast-Track Identification or Exclusion of Endometrial Cancer in Women with Postmenopausal Bleeding. Journal of Minimally Invasive Gynecology, 26, 516-525. https://doi.org/10.1016/j.jmig.2018.06.010
|
[32]
|
Jha, S., Singh, A., Sinha, H.H., et al. (2021) Rate of Premalignant and Malignant Endometrial Lesion in “Low-Risk” Premenopausal Women with Abnormal Uterine Bleeding Undergoing Endometrial Biopsy. Obstetrics & Gynecology Science, 64, 517-523. https://doi.org/10.5468/ogs.21150
|
[33]
|
Tameish, S., Florez, N., Vidal, J.R.P., et al. (2023) Transvaginal Ultra-sound versus Magnetic Resonance Imaging for Preoperative Assessment of Myometrial Infiltration in Patients with Low-Grade Endometrioid Endometrial Cancer: A Systematic Review and Head-to-Head Meta-Analysis. Journal of Clin-ical Ultrasound, 51, 1188-1197.
https://doi.org/10.1002/jcu.23508
|
[34]
|
Juan Luis Alcázar, M., Rosendo Galván, M., Albela, S., et al. (2009) As-sessing Myometrial Infiltration by Endometrial Cancer: Uterine Virtual Navigation with Three-Dimensional US. Radiol-ogy, 250, 776-783.
https://doi.org/10.1148/radiol.2503080877
|
[35]
|
Van Holsbeke, C., Ameye, L., Testa, A.C., et al. (2014) Develop-ment and External Validation of New Ultrasound-Based Mathematical Models for Preoperative Prediction of High-Risk Endometrial Cancer. Ultrasound in Obstetrics & Gynecology, 43, 586-595. https://doi.org/10.1002/uog.13216
|
[36]
|
Smet, F.D., Brabanter, J.D., Bosch, T.V.D., et al. (2006) New Models to Predict Depth of Infiltration in Endometrial Carcinoma Based on Transvaginal Sonography. Ultrasound in Obstetrics and Gynecology, 27, 664-671.
https://doi.org/10.1002/uog.2806
|
[37]
|
Verbakel, J.Y., Mascilini, F., Wynants, L., et al. (2020) Validation of Ultra-sound Strategies to Assess Tumor Extension and to Predict High-Risk Endometrial Cancer in Women from the Prospec-tive IETA (International Endometrial Tumor Analysis)-4 Cohort. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 55, 115-124. https://doi.org/10.1002/uog.20374
|
[38]
|
Epstein, E. and Blomqvist, L. (2014) Imaging in Endometrial Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 28, 721-739. https://doi.org/10.1016/j.bpobgyn.2014.04.007
|
[39]
|
Berg, H.F., Ju, Z., Myrvold, M., et al. (2020) Development of Prediction Models for Lymph Node Metastasis in Endometrioid Endometrial Carcinoma. British Journal of Cancer, 122, 1014-1022.
https://doi.org/10.1038/s41416-020-0745-6
|
[40]
|
Lee, J., Kong, T.W., Paek, J., et al. (2016) Predicting Model of Lymph Node Metastasis Using Preoperative Tumor Grade, Transvaginal Ultrasound, and Serum CA-125 Level in Pa-tients with Endometrial Cancer. International Journal of Gynecological Cancer, 26, 1630-1635. https://doi.org/10.1097/IGC.0000000000000820
|
[41]
|
Ignatov, T., Eggemann, H., Burger, E., et al. (2018) Ovarian Metastasis in Patients with Endometrial Cancer: Risk Factors and Impact on Survival. Journal of Cancer Research & Clinical Oncology, 144, 1103-1107.
https://doi.org/10.1007/s00432-018-2628-2
|
[42]
|
Pan, Z., Wang, X., Zhang, X., et al. (2011) Retrospective Analy-sis on Coexisting Ovarian Cancer in 976 Patients with Clinical Stage I Endometrial Carcinoma. Journal of Obstetrics & Gynaecology Research, 37, 352-358.
https://doi.org/10.1111/j.1447-0756.2010.01354.x
|
[43]
|
Hou, T., Li, Y.D., Liu, J.Y., et al. (2017) The Safety of Ovarian Preservation in Stage I Endometrial Endometrioid Adenocarcinoma Based on Propensity Score Matching. Com-binatorial Chemistry & High Throughput Screening, 20, 647-655. https://doi.org/10.2174/1386207320666170417145856
|
[44]
|
Shen, L., Xie, L., Li, R., et al. (2020) A Preoperative Prediction Model for Predicting Coexisting Adnexa Malignancy of Patients with G1/G2 Endometrioid Endometrial Can-cer. Gynecologic Oncology, 159, 402-408.
https://doi.org/10.1016/j.ygyno.2020.08.017
|